The Reuben community is delighted to wish hearty congratulations to Mark Coles, who has been recognised for his excellent academic achievements by being awarded the title of Professor. The award was announced through the University of Oxford's Recognition of Distinction Scheme, an annual exercise to confer the title of full professor to academics who make "a significant and sustained academic contribution to the University".
Mark, who leads the Cellular Life theme at Reuben, moved to his Oxford post from the University of York in 2017. His research focuses on understanding the immune system, and uses interdisciplinary approaches to discover and develop new therapeutics for rheumatoid arthritis, inflammatory disease and cancer. He is also part of the team in the Arthritis Therapy Acceleration Programme (A-TAP), an exciting new £7M concept funded by the Kennedy Trust for Rheumatology Research, that brings together the Universities of Birmingham and Oxford and seven NHS partners to support clinical inflammatory disease research and narrow the gap between bench and bedside.
Mark said about his award, “It is a fantastic honour to have been awarded a Kennedy Professorship in Immunology in NDORMS. As Director of Graduate studies in our department, I have had the privilege of supporting the Kennedy Trust Prize Studentship programme, developing the next generation of scientists to tackle chronic inflammatory human disease.”
Reuben College President, Lionel Tarassenko, said, "Promotion to a full Professorship is hugely deserved for Mark, and I'm delighted that the University has recognised the excellence of his research, which lies at the intersection between immunology and computational modelling. Mark has embraced the interdisciplinary ethos of Reuben College, and the whole college community congratulates him on this award."
